Is there a basis to set the acceptance criteria of the organic impurities in the specifications of drug substance and drug product for investigational new drug (IND) applications?
刊登日期:2019-11-11 | 點閱次數 : 397 次
Yes. At the clinical trial stage, the acceptance criteria of the organic impurities should be supported by the results of related toxicology studies.
|